This review article discusses the use of meso-2,3-dimercaptosuccinic acid (DMSA) as a safe, non-toxic, water-soluble treatment for heavy metal toxicity, particularly from lead, mercury, arsenic, and cadmium. DMSA has been shown to be an effective chelator, facilitating the excretion of heavy metals through urine while minimizing side effects compared to
This review article discusses the use of DMSA (dimercaptosuccinic acid) and DMPS (dimercaptopropanesulfonate) as safe and effective water-soluble chelating agents for treating heavy metal poisoning, including lead, mercury, arsenic, and cadmium. Both agents are shown to be effective in promoting the excretion of toxic metals while having minimal side effects
This review article reappraises the clinical use of EDTA chelation therapy, highlighting its effectiveness in removing toxic metals such as lead, cadmium, nickel, and aluminum. Based on recent clinical trials, EDTA therapy showed benefits such as a 50% reduction in urinary lead levels and improved systolic blood pressure in cardiovascular
This study investigated the effectiveness of a single edetate disodium-based infusion in enhancing the excretion of vasculotoxic metals in patients who had experienced a myocardial infarction. The results showed a significant increase in the urinary excretion of lead, cadmium, and other metals post-infusion (p
